Risk of Unexplained Acute Liver Failure in Diabetes Mellitus [3] (multiple letters)

Archives of Internal Medicine

Volumn 163, Issue 21, 2003, Pages 2649-2651

  Graham, David J ^a,b   Chan, K Arnold ^a   Truman, Alison ^a   Gurwitz, Jerry H ^a   Hurley, Judith ^a   Martinson, Brian ^a   Platt, Richard ^a   Moeley, Richard ^a   Selby, Joe ^a  

^a Food and Drug Administration ^*

^b CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDIABETIC AGENT; INSULIN; TROGLITAZONE;

BRAIN DISEASE; CARDIOGENIC SHOCK; CLINICAL FEATURE; DIABETES MELLITUS; DRUG MARKETING; HOSPITALIZATION; HUMAN; INCIDENCE; INSULIN TREATMENT; JAUNDICE; LETTER; LIVER FAILURE; LIVER INJURY; LIVER TRANSPLANTATION; MEDICAL DECISION MAKING; PRIORITY JOURNAL; RISK FACTOR; UNITED STATES; VIRUS HEPATITIS;

EID: 0345714957     PISSN: 00039926     EISSN: None     Source Type: Journal    
DOI: 10.1001/archinte.163.21.2649-b     Document Type: Letter

References (0)